Literature DB >> 16464584

The spermicidal and antitrichomonas activities of SSRI antidepressants.

V S Kiran Kumar1, Vishnu Lal Sharma, Pratibha Tiwari, Divya Singh, Jagdamba Prasad Maikhuri, Gopal Gupta, Man Mohan Singh.   

Abstract

The study investigated spermicidal and antitrichomonas activities of selective serotonin reuptake inhibitor (SSRI) antidepressants with a view to generate new lead for development of dual-function spermicidal microbicides, which is an urgent global need. Fluoxetine, Sertraline, and Fluvoxamine exhibited both spermicidal and anti-STI (antitrichomonas) activities in vitro, whereas Paroxetine and Citalopram showed only the spermicidal activity. Fluoxetine exhibited better activity profile than the other antidepressant drugs with its spermicidal and antitrichomonas activities being comparable to that of the OTC contraceptive Nonoxynol-9. The non-detergent nature of Fluoxetine and a much lower spermicidal ED50 value (than N-9) may add considerably to its merit as a candidate for microbicidal contraceptive. Thus, the antidepressants exhibiting both spermicidal and antitrichomonas activities might provide useful lead for the development of novel, dual-function spermicidal contraceptives.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16464584     DOI: 10.1016/j.bmcl.2006.01.078

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  15 in total

1.  Paternal dapoxetine administration induced deterioration in reproductive performance, fetal outcome, sexual behavior and biochemistry of male rats.

Authors:  R ElMazoudy; N AbdelHameed; A ElMasry
Journal:  Int J Impot Res       Date:  2015-09-24       Impact factor: 2.896

2.  Novel trichomonacidal spermicides.

Authors:  Ashish Jain; Nand Lal; Lokesh Kumar; Vikas Verma; Rajeev Kumar; Lalit Kumar; Vishal Singh; Raghav K Mishra; Amit Sarswat; S K Jain; J P Maikhuri; V L Sharma; Gopal Gupta
Journal:  Antimicrob Agents Chemother       Date:  2011-06-27       Impact factor: 5.191

Review 3.  Adverse effects of common medications on male fertility.

Authors:  Mary K Samplaski; Ajay K Nangia
Journal:  Nat Rev Urol       Date:  2015-06-23       Impact factor: 14.432

4.  The antidepressant sertraline provides a promising therapeutic option for neurotropic cryptococcal infections.

Authors:  Bing Zhai; Cheng Wu; Linqi Wang; Matthew S Sachs; Xiaorong Lin
Journal:  Antimicrob Agents Chemother       Date:  2012-04-16       Impact factor: 5.191

Review 5.  FDA-approved drugs that are spermatotoxic in animals and the utility of animal testing for human risk prediction.

Authors:  Elizabeth R Rayburn; Liang Gao; Jiayi Ding; Hongxia Ding; Jun Shao; Haibo Li
Journal:  J Assist Reprod Genet       Date:  2017-10-24       Impact factor: 3.412

6.  Effect of fluoxetine on the testes of adult albino rats and the possible protective role of curcumin.

Authors:  Basma Fathi Elsedawi; Youssef Hussein; Mohamed Ahmed Sabry; Joseph Amin Aziz
Journal:  Anat Sci Int       Date:  2020-10-14       Impact factor: 1.741

7.  Molecular Basis of the Leishmanicidal Activity of the Antidepressant Sertraline as a Drug Repurposing Candidate.

Authors:  Marta L Lima; María A Abengózar; Montserrat Nácher-Vázquez; María P Martínez-Alcázar; Coral Barbas; Andre G Tempone; Ángeles López-Gonzálvez; Luis Rivas
Journal:  Antimicrob Agents Chemother       Date:  2018-11-26       Impact factor: 5.191

Review 8.  FDA-approved medications that impair human spermatogenesis.

Authors:  Jiayi Ding; Xuejun Shang; Zhanhu Zhang; Hua Jing; Jun Shao; Qianqian Fei; Elizabeth R Rayburn; Haibo Li
Journal:  Oncotarget       Date:  2017-02-07

9.  Paternal use of antidepressants and offspring outcomes in Sweden: nationwide prospective cohort study.

Authors:  Alexander Viktorin; Stephen Z Levine; Margret Altemus; Abraham Reichenberg; Sven Sandin
Journal:  BMJ       Date:  2018-06-08

10.  Effects of pharmaceutical medications on male fertility.

Authors:  Paul R Brezina; Fahd N Yunus; Yulian Zhao
Journal:  J Reprod Infertil       Date:  2012-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.